FDA Investigator Bing Lin
Bing Lin has inspections in 14 countries as of 08 Mar 2024. Bing Lin has collaborated with a combinined 3413 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
156
Last Inspection Date:
08 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Italy,
Japan,
Taiwan,
China,
Viet Nam,
Chile,
Malaysia,
Argentina,
Thailand,
Singapore,
United Kingdom of Great Britain and Northern Ireland,
Netherlands
Co-Investigator(s):
Adam C Hipko,
Adrian Rodriguez,
Akbar J Zaidi,
Alcee M Tavarez,
Amanda J White,
Andrew J Howard,
Andrew J Lang,
Angela Mock,
Angele C Smith,
Anh M Lac,
Annemarie Bodnar,
Anya D Lockett Evans,
April K Hill,
Arie R Dyk,
Ashley N Williams,
Axel M Ambert,
Betsy C Galliher,
Bevill,
Blondell W Johnson,
Bonnie L Menzel,
Brackens Harris,
Brandi E Williams,
Brandon K Barbee,
Brandon K Lawson,
Brandon O Neloms,
Brian Sanders,
Brook Shea,
Camille D Brown,
Carol A Declouette Wilburn,
Casey L Hamblin,
Cassandra L Abellard,
Castellaw,
Cathleen A Castellaw,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Cheryl G Scott,
Chmura,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher K Gibbs,
Christopher L Jacobs,
Clara E Santiago,
Coleen L Manoy,
Connie L Hannon Rabel,
Constance M Dobbins,
Crystal A Harlan,
Crystal S Harris,
Crystal S Harris Smith,
Cymbre Weatherly,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Debbie J Cunningham,
Debra D Devlieger,
Decarlos A Gomez,
Denise Connelly,
Deniza Karacic,
Devon Jenkins,
Dirk L Lincoln,
Ed Gonzalez Vazquez,
Edna J Hidalgo,
Elisa M Fleming,
Elizabeth D Connell,
Elizabeth P Mayer,
Elkins,
Elvia J Cervantes,
Enspect User,
Ernest Serna, III,
Fernando C Martinez,
Frans E Mercado,
Fred R Strominger,
Gale L Glinecki,
Gatica,
Glasgow,
Grant,
Grant L Davis,
Gregory A Holt,
Hala L Selby,
Haley L Coleman,
Harrisv,
Holly J Rapier,
Hudson,
Hung V Le,
Hurst,
Iris C Macinnes,
Jacey Roy,
Jacob W Reynolds,
Jamie M Bumpas,
Jane M Broussard,
Janice M Hickok,
Jason P Aun,
Jeffrey R Wooley,
Jennifer D Young,
Jennifer Owens Dowdy,
Jeremy L Stukes,
Jodi M Gatica,
Jogy George,
Johann M Fitch,
Johnson,
Jonaida Estevez Martinez,
Jonathan A Womack,
Jonathan M Mcbride,
Joshua L Gibbs,
Joy L Ramsey,
Juan D Lopez,
Judith A Jones,
Justin A Boyd,
Kamara Tx,
Kari M Johansen,
Karlton T Watson,
Kayla R Deatherage,
Keith A Schwartz,
Kenitra D Hewitt,
Khunnathee Stoner,
King,
Kristen E Szenderski,
Kristin N Longfellow,
Krystyna M Kitson,
Kunapuli T Madhusudhan,
Latorie S Jones,
Lauren E Skokan,
Lauren R Brady,
Lauren R Howell,
Lawrence C Coleman,
Leighton K Ngai,
Lisa M Puttonen,
Lisa M Yoder,
Lisa R Jennings,
Lisa R Whitt,
Liza L Quiles,
Lloyd D Payne,
Loan T Tran,
Loretta Nemchik,
Lorie S Hannappel,
Lourdes R Genera,
Luis E Gonzalez,
Maira P Brading,
Marc R Dickens,
Marcelo O Mangalindan, Jr,
Margaret M Annes,
Margarito J Uribe,
Margo C Jones,
Martha S Baldwin,
Martin K Essary,
Massoud Motamed,
Matthew S Mccollough,
Michael L Jones,
Monique Rac Lester,
Ninfa N Innocent,
Osama A Khatib,
Patrick D Stone, MS,
Paul E Frazier,
Paula J Perry,
Pauline N Logan,
Payne,
Philip M Steele, PhD,
Phillip J Sample,
Raymond L Cheung,
Raymond M Lam,
Rebecca C O Bryan,
Rebecca M Allen,
Rene R Ramirez,
Renee Johnson, RS,
Rhonda L Dash,
Rian L Pope,
Robert T Harris,
Robert T Lorenz,
Rodriguez,
Rowena Trevino Solis,
Roy Baby,
Saleem A Akhtar,
Sandy J Ziegler,
Sara A Valenzuela,
Sarah L Fredric,
Scott R Nichols, PhD,
Scott T Ballard,
Sean M Cheney,
Selina M Mata,
Seri Essary,
Seri L Essary,
Shannon A Lowe,
Shawn E Larson,
Staci G Mcallister,
State Agency,
Tamera H Hunt,
Tara A Gray,
Theresa Kirkham (NMI),
Timothy B Webb,
Toby Vern H Hill,
Torrance J Slayton,
Tracy J Washington,
Travis M Beard,
Travis S Brown,
Tricia S Martinez,
Trina K Vick,
Tuan A Nguyen,
Verlinda A Narcisse,
Yaw O Osei,
Young M Yoon
Bing Lin's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2021 | FDA 483 | Cosmax Nbt Usa, Inc. - Form 483, 2021-05-04 |
December, 2016 | FDA 483 | Kraft Heinz Company - Form 483, 2016-12-09 |
December, 2023 | FDA 483 | Mead Johnson & Company LLC - Form 483, 2023-12-01 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more